#Cytiva collaborate#drug development#accelerate characterization#Nuclera#Cytiva
#Medical Device#Device Network#Illumina widens#widens access#cancer tests
#unveils PromoterAI#Illumina unveils#groundbreaking algorithm#accelerate insights#rare disease
#Genomics laying#Pleasanton Weekly#local workers#Weekly Pleasanton-based#workers Pleasanton
#Subsidiary Seeks#Quash Subpoena#Subpoena Issued#Denosumab Litigation#Cytiva Subsidiary
#Illumina expands#expands clinical#clinical oncology#oncology portfolio#portfolio unlocking
#Business Weekly#ally boost#boost protein#Weekly Nuclera#protein proposition
#Corporation Announces#Announces Acquisition#Halo Labs#Spectroscopy Online#Waters Corporation
#Element Biosciences#Alleging Infringement#Flow Cell#Genetic Engineering#Imaging Patents
#TRU Global#Global Solutions#chooses TRU#Cleanroom Technology#Lonza chooses
#Genetic Engineering#Cost-Cutting Effort#Effort GEN#Eliminates#Genetic
#Chief Legal#Corporate Affairs#Appoints Andreas#Andreas Bohrer#Affairs Officer
#JUVE Patent#Bruker settle#landmark UPC#UPC dispute#settle landmark
#Genomics Announces#Announces Patent#Patent Litigation#Litigation Settlement#Settlement Agreement
#rRNA gene#Comparative analysis#gene sequencing#gut microbiota#Frontiers Comparative
#Indianapolis diagnostics#Roche announces#million investment#diagnostics manufacturing#Newswire Roche
#Lonza Confirms#Confirms Strong#call transcript#Earnings call#Investing.com Earnings
#SEC ends#Grail acquisition#Dive SEC#MedTech Dive#ends probe
#Genomics Reports#Financial Results#Genomics#Quarter#Financial
#Genetic Engineering#CGT Production#Speed Delivery#Lower Cost#Improving CGT